Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.6044
+0.0184 (3.14%)
At close: Jun 27, 2025, 4:00 PM
0.6001
-0.0043 (-0.71%)
After-hours: Jun 27, 2025, 7:52 PM EDT

Dermata Therapeutics Statistics

Total Valuation

DRMA has a market cap or net worth of $3.85 million. The enterprise value is -$5.86 million.

Market Cap 3.85M
Enterprise Value -5.86M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date Aug 6, 2025
Ex-Dividend Date n/a

Share Statistics

DRMA has 6.38 million shares outstanding. The number of shares has increased by 835.23% in one year.

Current Share Class 6.38M
Shares Outstanding 6.38M
Shares Change (YoY) +835.23%
Shares Change (QoQ) +49.99%
Owned by Insiders (%) 16.90%
Owned by Institutions (%) 1.69%
Float 4.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.50
P/TBV Ratio 0.53
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.70

Current Ratio 3.70
Quick Ratio 3.59
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -206.26% and return on invested capital (ROIC) is -131.08%.

Return on Equity (ROE) -206.26%
Return on Assets (ROA) -95.90%
Return on Invested Capital (ROIC) -131.08%
Return on Capital Employed (ROCE) -159.56%
Revenue Per Employee n/a
Profits Per Employee -$1.43M
Employee Count 8
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.02% in the last 52 weeks. The beta is 0.57, so DRMA's price volatility has been lower than the market average.

Beta (5Y) 0.57
52-Week Price Change -77.02%
50-Day Moving Average 0.75
200-Day Moving Average 1.15
Relative Strength Index (RSI) 30.31
Average Volume (20 Days) 94,506

Short Selling Information

The latest short interest is 68,112, so 1.07% of the outstanding shares have been sold short.

Short Interest 68,112
Short Previous Month 62,894
Short % of Shares Out 1.07%
Short % of Float 1.64%
Short Ratio (days to cover) 0.94

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.65M
Pretax Income -9.82M
Net Income -11.46M
EBITDA n/a
EBIT -11.65M
Earnings Per Share (EPS) -$4.23
Full Income Statement

Balance Sheet

The company has $9.72 million in cash and n/a in debt, giving a net cash position of $9.72 million or $1.52 per share.

Cash & Cash Equivalents 9.72M
Total Debt n/a
Net Cash 9.72M
Net Cash Per Share $1.52
Equity (Book Value) 7.30M
Book Value Per Share 1.21
Working Capital 7.30M
Full Balance Sheet

Cash Flow

Operating Cash Flow -10.39M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DRMA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -835.23%
Shareholder Yield -835.23%
Earnings Yield -297.20%
FCF Yield n/a

Analyst Forecast

The average price target for DRMA is $3.00, which is 396.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target $3.00
Price Target Difference 396.36%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 16, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date May 16, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1